Peak6 Investments LLC Myriad Genetics Inc Put Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $1,821 - $2,788	-100 Reduced 1.28%	7,700 $147,000
Q2 2022 Aug 12, 2022	BUY	$16.45 - $25.88 $126,665 - $199,276	7,700 Added 7700.0%	7,800 $142,000
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $2,267 - $2,801	100 New	100 $3,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $2.1 Million - $3.24 Million	-92,700 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $16,158 - $20,820	-600 Reduced 0.64%	92,700 $3.08 Million
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $931,266 - $1.56 Million	34,200 Added 57.87%	93,300 $2.71 Million
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $2.22 Million - $2.98 Million	59,100 New	59,100 $2.72 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.